These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17644246)

  • 1. Nonthymoma early-onset- and late-onset-generalized myasthenia gravis--a retrospective hospital-based study.
    Chan KH; Cheung RT; Mak W; Ho SL
    Clin Neurol Neurosurg; 2007 Oct; 109(8):686-91. PubMed ID: 17644246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
    Wong V; Hawkins BR; Yu YL
    Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
    J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese.
    Lee CY; Lam CL; Pang SY; Lau KK; Teo KC; Chang RS; Chan KH
    J Neuroimmunol; 2015 Dec; 289():177-81. PubMed ID: 26616888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
    Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
    J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to treatment of myasthenia gravis according to clinical subtype.
    Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
    BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognosis of very late-onset myasthenia gravis in China.
    Tang YL; Ruan Z; Su Y; Guo RJ; Gao T; Liu Y; Li HH; Sun C; Li ZY; Chang T
    Neuromuscul Disord; 2023 Apr; 33(4):358-366. PubMed ID: 36990040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
    Eur Neurol; 2003; 49(4):210-7. PubMed ID: 12736536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
    Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y
    Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and outcomes of myasthenia gravis patients with double positive antibodies against acetylcholine receptor and muscle-specific tyrosine kinase].
    Lu YR; Yu L; Ma Q; Chen P; Qiu L; Ou CY; Lin ZZ; Liu WB
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):942-947. PubMed ID: 35385966
    [No Abstract]   [Full Text] [Related]  

  • 14. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
    Hong Y; Skeie GO; Zisimopoulou P; Karagiorgou K; Tzartos SJ; Gao X; Yue YX; Romi F; Zhang X; Li HF; Gilhus NE
    J Neurol; 2017 May; 264(5):955-962. PubMed ID: 28364296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
    Monte G; Spagni G; Damato V; Iorio R; Marino M; Evoli A
    J Neurol; 2021 May; 268(5):1803-1807. PubMed ID: 33387011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
    Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
    J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: a study from India.
    Singhal BS; Bhatia NS; Umesh T; Menon S
    Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
    Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.